CIK: 1238401 - Address: C/O Newamsterdam Pharma Company N.V., Gooimeer 2-35, Naarden, P7 1411 DC
14 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/27/19 16:10
12/23/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-65659.600-11-3315M
9/25/19 18:11
9/23/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-35432.160-11-3326M
6/26/19 16:07
6/24/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-79437.790-21-6337M
3/27/19 17:03
3/25/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-77636.000-22-6358M
12/27/18 17:43
12/24/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-59618.620-32-8380M
11/16/18 18:34
11/15/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-54022.490-24-6412M
9/26/18 19:00
9/24/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-1,23337.380-33-7436M
6/27/18 18:51
6/25/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-1,33940.590-33-7472M
3/28/18 21:11
3/26/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-1,38728.890-48-9506M
12/26/17 19:38
12/22/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-55630.880-18-3550M
9/29/17 17:47
9/29/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-31228.350-11-2574M
9/26/17 17:44
9/25/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-51028.320-18-3587M
6/28/17 16:42
6/26/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLange Louis GCADS-29719.780-15-2597D
4/3/09 14:14
4/2/09
CVTXCv Therapeutics IncDEHealthBioPrdBiological Products, (No DiagLange Louis GCADOCB,CEOS.d-9,53619.900-479-48510D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact